ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this article with:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

I have had the pleasure of working closely with the XVIVO team for the past year and half as we prepared for launch. They have contributed to building a sound foundation for communicating our clinical messaging across multiple mediums and channels. XVIVO’s scientific rigor and technical expertise exceed any I have seen within the industry. The XVIVO team consists of highly professional engaging personnel that have mastered their respective areas of work. XVIVO are fun and engaging partners. The products that XVIVO consistently delivered elevated the power of our story.

Intuniv Marketing, Shire LLC.